UK Companies House feature
OXEHEALTH LIMITED
Profile
- Company number
- 08163325
- Status
- Active
- Incorporation
- 2012-07-31
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 62090
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Corrigan Accountants Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the Directors consider to be appropriate for the following reasons. The Directors have considered the Group's liquidity position. The Group is investor funded and has sufficient funding in place to secure the business beyond the going concern consideration timeframe of 12 months. At 31 December 2024, the Group had £1,818,955 of cash and cash equivalents and net current liabilities of £(6,454,116). As detailed in the post balance sheet events note, a fundraise completed in March 2025 gave rise to an additional £2.1m of capital being invested in the business. Consequently, the Directors are confident that the Group will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”
Subsidiaries
- Oxehealth Inc. · 100% held · USA
- Oxehealth AB · 100% held · Sweden
Significant events
- “Since the end of 2024, the Group has issued a total of 203,839 shares for a gross cash consideration of £3,546,973.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ROSE, Danny | Secretary | 2025-04-01 | — | — |
| EDE-GOLIGHTLY, James Lawrence | Director | 2016-05-20 | Aug 1979 | British |
| GENOVESE, Michael Vincent, Dr | Director | 2025-01-28 | Sep 1970 | American |
| GOODWIN, Jacob Lawley | Director | 2023-03-22 | Oct 1988 | British |
| HAEDRICH, Todd | Director | 2024-02-27 | May 1971 | American |
| TARASSENKO, Lionel, Professor | Director | 2012-08-01 | Apr 1957 | British |
| IP2IPO SERVICES LIMITED | Corporate Director | 2012-09-13 | — | — |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HARDMAN, Simon | Secretary | 2017-06-29 | 2020-04-06 |
| HATFIELD, Thomas Michael | Secretary | 2021-02-22 | 2025-04-01 |
| MITCHELL, Guy James | Secretary | 2020-04-06 | 2021-02-22 |
| IP2IPO SERVICES LIMITED | Corporate Secretary | 2014-01-03 | 2017-06-29 |
| CHEVALLIER, Jonathan Nigel Mayne | Director | 2013-08-15 | 2016-08-24 |
| HARDMAN, Simon | Director | 2018-01-24 | 2020-02-18 |
| HATFIELD, Thomas Michael | Director | 2021-02-25 | 2025-02-18 |
| HILL, Michael Ian | Director | 2016-09-01 | 2021-11-30 |
| LLOYD-JUKES, Hugh | Director | 2016-08-24 | 2023-12-31 |
| LLOYD-JUKES, Hugh | Director | 2015-05-08 | 2016-05-20 |
| QUINN, Bernard Paul | Director | 2017-07-26 | 2022-12-31 |
| REDFORD, Iain Peter | Director | 2012-07-31 | 2012-08-01 |
| WENSLEY STOCK, Benjamin Paul | Director | 2013-10-22 | 2016-05-20 |
| WOOD, Allan Leigh | Director | 2013-05-01 | 2017-08-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Top Technology Ventures Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2021-04-16 | Active |
| Ip2ipo Portfolio (Gp) Limited | Corporate entity | Significant influence | 2017-06-13 | Ceased 2021-04-16 |
| Ora Limited | Corporate entity | Significant influence | 2016-04-06 | Ceased 2021-04-16 |
| Ip2ipo Limited | Corporate entity | Significant influence | 2016-04-06 | Ceased 2017-06-13 |
| The Wellcome Trust Limited | Corporate entity | Significant influence | 2016-04-06 | Ceased 2016-05-20 |
Filing timeline
Last 20 of 171 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-16 | SH01 | capital | capital allotment shares |
| 2026-02-05 | SH01 | capital | capital allotment shares |
| 2025-09-17 | AA | accounts | accounts with accounts type group |
| 2025-08-07 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-08-06 | AD02 | address | change sail address company with old address new address |
| 2025-08-05 | SH01 | capital | capital allotment shares |
| 2025-07-11 | SH01 | capital | capital allotment shares |
| 2025-04-23 | SH01 | capital | capital allotment shares |
| 2025-04-09 | SH01 | capital | capital allotment shares |
| 2025-04-01 | TM02 | officers | termination secretary company with name termination date |
| 2025-04-01 | AP03 | officers | appoint person secretary company with name date |
| 2025-02-18 | TM01 | officers | termination director company with name termination date |
| 2025-01-29 | AP01 | officers | appoint person director company with name date |
| 2025-01-09 | SH01 | capital | capital allotment shares |
| 2024-11-27 | SH01 | capital | capital allotment shares |
| 2024-10-18 | SH01 | capital | capital allotment shares |
| 2024-10-01 | AD01 | address | change registered office address company with date old address new address |
| 2024-08-18 | AA | accounts | accounts with accounts type group |
| 2024-08-08 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-08-02 | SH01 | capital | capital allotment shares |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory